Windtree Therapeutics $520M BNB Deal: A Bold Crypto Pivot Explained

Discover how Nasdaq-listed Windtree Therapeutics' $520M funding deal to buy BNB shakes up the biotech and crypto markets. Learn the risks and opportunities!

July 25, 2025